Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute and Honorary Professor of Medicine at Cardiff University School of Medicine, shared a post on LinkedIn:
“At 5 years, brain metastases occurred in 2.6% of pCR patients with Her2 positive breast cancer . These findings indicate that pCR does not eliminate the risk of brain metastases, highlighting the need for continued vigilance.”
Title: Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response
Authors: Mayako Terao, Hiraku Kumamaru, Naoko Kinukawa, Toru Hanamura, Yasuaki Sagara, Takayuki Iwamoto, Minoru Miyashita, Takanori Ishida, Naruto Taira, Shigehira Saji, Naoki Niikura.
Read the article here.
Other articles about Breast Cancer on OncoDaily.